Cargando…
The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways
BACKGROUND: The formation of new lymphatic vessels provides an additional route for tumour cells to metastasize. Therefore, inhibiting lymphangiogenesis represents an interesting target in cancer therapy. First evidence suggests that histone deacetylase inhibitors (HDACi) may mediate part of their a...
Autores principales: | Hrgovic, Igor, Doll, Monika, Kleemann, Johannes, Wang, Xiao-Fan, Zoeller, Nadja, Pinter, Andreas, Kippenberger, Stefan, Kaufmann, Roland, Meissner, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045659/ https://www.ncbi.nlm.nih.gov/pubmed/27716272 http://dx.doi.org/10.1186/s12885-016-2807-y |
Ejemplares similares
-
Peroxisome proliferator-activated receptor (PPAR) α and δ activators induce ICAM-1 expression in quiescent non stimulated endothelial cells
por: Naidenow, Julia, et al.
Publicado: (2016) -
Dimethylfumarate protects against TNF-α-induced secretion of inflammatory cytokines in human endothelial cells
por: Gerhardt, Simon, et al.
Publicado: (2015) -
Dimethylfumarate Inhibits Colorectal Carcinoma Cell Proliferation: Evidence for Cell Cycle Arrest, Apoptosis and Autophagy
por: Kaluzki, Irina, et al.
Publicado: (2019) -
Acting without Central Agent—Considerations for a Self-Model at the Cellular Level
por: Kippenberger, Stefan, et al.
Publicado: (2017) -
The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses
por: Moreira, José Manuel Afonso, et al.
Publicado: (2003)